Status:

RECRUITING

Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health

Lead Sponsor:

Universiti Teknologi Mara

Collaborating Sponsors:

Ministry of Higher Education, Malaysia

Conditions:

Myocardial Infarction

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to learn about the effects of time-restricted eating in patients with history of acute coronary syndrome. The main questions it aims to answer are: 1) Is 10-hr TRE s...

Detailed Description

Justification: The effects of TRE on humans varies results, with some showing improvements in weight loss, insulin sensitivity, and cardiovascular markers, while others exhibiting no significant chang...

Eligibility Criteria

Inclusion

  • Adult, 18- 65 years old.
  • Had history of acute coronary syndrome (ACS)
  • Clinically stable
  • Self-reported eating window of at least 12 h per day.

Exclusion

  • Severe obesity (body mass index ≥40 kg m-2).
  • Unstable weight in the past three months (gain or lose more than 4 kg of weight).
  • Unstable cardiovascular, renal, cardiac, liver, lung, adrenal, or nervous system disease that may compromise study validity.
  • Any medications or supplements known to change sleep, circadian rhythms, or metabolism.
  • Pregnant or lactating women.
  • Perform overnight shift work more than one day/week on average.
  • Regularly fasted for more than 15 hours/day or having completed twelve 24-hr fasts within the past three months).
  • Active use of tobacco or illicit drug or history of treatment for alcohol abuse.
  • Type I diabetes or diabetic, treated with insulin.
  • Use of anti-obesity drugs or other drugs affecting body weight.
  • Currently enrolled in weight loss or management programme, including surgical intervention.
  • Severe kidney failure (glomerular filtration rate (GFR) \<30 mL/min).
  • Eating disorder or current diagnosis of uncontrolled psychiatric illness, which may impair study involvement.
  • Malignancy undergoing active treatment.
  • Had gastrointestinal surgery or impaired nutrient absorption.
  • Travelled more than two time zones away two months prior to enrolling in the trial or will travel more than two time zones away during the study period.
  • Concurrent participation in other interventional studies

Key Trial Info

Start Date :

September 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2025

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT06007950

Start Date

September 1 2023

End Date

September 1 2025

Last Update

July 18 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pusat Perkhidmatan Klinikal (CTC) UiTM

Kuala Selangor, Malaysia